Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 14, 2017; 23(26): 4815-4822
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4815
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4815
Sex | Age, yr | Weight, kg | Preoperative chemotherapy | Comorbidities | CLM | |
Patient 1 | Female | 52 | 55 | Oxaliplatin | None | Metachronous |
Patient 2 | Female | 61 | 63 | Oxaliplatin | SAH | Metachronous |
Patient 3 | Female | 39 | 98 | Oxaliplatin + bevacizumab | None | Synchronous |
Patient 4 | Female | 54 | 66 | Oxaliplatin | None | Metachronous |
Patient 5 | Female | 65 | 46 | Oxaliplatin | DM, SAH | Metachronous |
- Citation: Balzan SMP, Gava VG, Magalhães MA, Dotto ML. Extreme liver resections with preservation of segment 4 only. World J Gastroenterol 2017; 23(26): 4815-4822
- URL: https://www.wjgnet.com/1007-9327/full/v23/i26/4815.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i26.4815